WHWK Stock Analysis: Buy, Sell, or Hold?
WHWK - Whitehawk Therapeutics, Inc. Common Stock
$3.84
-0.13 (-3.27%)
âŧ
5d:
-4.48%
30d:
-4.48%
90d:
+13.27%
WAIT
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 06, 2026
22d
Get Alerted When WHWK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: WHWK is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: WHWK is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: WHWK is currently trading at $3.84, which is considered fair relative to its 30-day fair value range of $4.09 to $4.44.
Technical Outlook: Technically, WHWK is in a strong uptrend. The price is currently testing key support at $3.96. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: WHWK has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $7.20 (+87.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, WHWK is in a strong uptrend. The price is currently testing key support at $3.96. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.3% recently.
Market Sentiment: WHWK has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $7.20 (+87.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$4.09 -
$4.44
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
44.7%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.3%)
- BULLISH: Trading 87.5% below Wall St target ($7.20)
Trading Range Analysis
30-Day Trading Range
$4.09 -
$4.44
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$3.96
Resistance Level
$5.00
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.29
Wall Street Target
$7.20
(+87.5%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: July 14, 2026 1:21 AM ET
Data refreshes hourly during market hours. Next update: 2:21 AM
Data refreshes hourly during market hours. Next update: 2:21 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is WHWK showing a specific setup today?
Insider Activity (6 Months)
0
Buys
14
Sells
Net
INSIDERS SELLING
Recent Transactions
Scott M Giacobello
SELL
141600 shares
2026-04-16
Scott M Giacobello
SELL
77000 shares
2026-04-15
Bryan Ball
SELL
92460 shares
2026-04-14
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$258 | 67 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 61 BUY |
|
DNTH
Dianthus Therapeutics InâĻ |
STRONG BUY
12 analysts |
$128 | 59 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$51 | 49 HOLD |
|
CNTA
Centessa PharmaceuticalsâĻ |
STRONG BUY
11 analysts |
$44 | 61 BUY |